E-MTAB-1172
Whole exome sequencing suggests much of non BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
Whole exome sequencing identification of putative founder mutations in non-BRCA1/2 breast cancer patients
Whole exome sequencing identification of putative founder mutations in non-BRCA1/2 breast cancer patients